CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,488 | $495.77 | $738K | 327,445 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,484 | $496.83 | $737K | 325,961 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,358 | $497.73 | $676K | 324,603 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $499.07 | $80K | 324,443 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 385,410 | ||
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,520 | $492.97 | $749K | 332,423 |
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,680 | $493.60 | $1.3M | 329,743 |
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,170 | $494.82 | $1.1M | 327,573 |
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,287 | $495.71 | $1.1M | 325,286 |
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −843 | $496.62 | $419K | 324,443 |
| 2026-09-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 394,910 | ||
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −248 | $492.91 | $122K | 333,695 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,216 | $493.78 | $1.1M | 331,479 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −4,269 | $494.70 | $2.1M | 327,210 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,330 | $495.66 | $1.2M | 324,880 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −277 | $496.64 | $138K | 324,603 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $498.25 | $80K | 324,443 |
| 2026-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 404,410 |
Page 34 of 121 · 2,404 trades